Xilio Therapeutics, Inc.XLONASDAQ
Loading
Debt Growth Under PressureDecelerating
Percentile Rank32
Studio
Year-over-Year Change

Year-over-year debt growth rate

Percentile
P32
Within normal range
vs 3Y Ago
-1.1x
Contraction
Streak
5 qtr
Consecutive declineDecelerating
PeriodValue
Q3 2025-4.00%
Q2 2025-3.79%
Q1 2025-3.41%
Q4 2024-3.24%
Q3 2024-3.15%
Q2 2024-2.85%
Q1 2024-21.93%
Q4 2023-20.73%
Q3 2023-14.01%
Q2 2023-7.18%
Q1 2023-9.18%
Q4 2022-4.99%
Q3 20223.64%
Q2 2022-4.63%
Q1 20222.39%
Q4 20210.32%
Q3 2021-0.39%
Q2 2021-2.23%
Q1 2021-3.03%
Q4 20200.00%
Q3 20200.00%
Q2 20200.00%
Q1 20200.00%